VeriSeq v2 NIPTVeriSeq v2 NIPT - view 2VeriSeq v2 NIPT - view 3VeriSeq v2 NIPT - view 4VeriSeq v2 NIPT - view 5VeriSeq v2 NIPT - view 6 1 / 6
VeriSeq v2 NIPT
Patient reviews

VeriSeq v2 NIPT

£325 from 10 weeks · Singleton and twin pregnancies
200+ collection locations near you Find your nearest

Non-invasive prenatal screen from 10 weeks, analysed on Illumina's VeriSeq v2 platform at TDL Genetics in the UK. Screens the 3 most common chromosomal conditions plus optional fetal sex, with a 3-4 day turnaround.

Turnaround time 3-4 working days
Affects pregnancies 1 in 240*
Most advanced labs Accurate testing →

Choose your collection method

Klarna's credit agreements are not regulated by the FCA. Use of these and any missed payments may affect your ability to obtain credit from Klarna and other lenders. 18+, UK residents only. Subject to status. T&Cs apply. Klarna terms apply.

● In stock · Secure checkout via Stripe

Analysed on Illumina's VeriSeq v2 platform at TDL Genetics (The Doctors Laboratory) in the UK

Detection rate >99% for Down's syndrome (trisomy 21); optional fetal sex reporting

Free midwife consultation before you take the test

Results reviewed by your midwife; specialist follow-up if high-risk

Common NIPT questions, and what a positive result really means.

What this test screens for
3
conditions checked In a single non-invasive test
Useful information

The logistics, simply.

Everything you need to know about shipping, blood draw, and suitability.

Kit delivery & logistics

1. Get your kit from us. Free delivery of your test kit, dispatched by next-day delivery after your free 20-minute specialist midwife consultation and once your test choice is confirmed. Changed your mind? Return the kit unused within 30 days at no charge.

2. Easy returns. After sample collection, send your sample in the pre-paid bag to the nearest depot (details in your email). Turnaround is counted in working days from when your sample reaches the laboratory.

Turnaround
3-4 working days
Laboratory
TDL Genetics, UK

Sample / draw options

Maternal blood draw : A standard blood draw from the pregnant person - no risk to the pregnancy.

Test suitability

Suitable for singleton and twin pregnancies, including IVF pregnancies (both own-egg and egg-donor). Best performed between from 10 weeks and 16 weeks of pregnancy.

Not suitable for pregnancies beyond 16 weeks, triplet (or higher-order) pregnancies, or where the patient has a history of chromosomal abnormalities, parental mosaicism, fetal demise, an active malignancy, or a previous bone marrow / organ transplant.

Genetic testing with Jeen Health is only available to individuals aged 18 and over.

⚠ If your pregnancy has progressed beyond 16 weeks, please reach out before booking. Our genetic counsellors will discuss your circumstances and recommend the most suitable option.

How it works

Three steps. That's it.

Simple, clinician-supported steps to take your test with Jeen.

01

Talk to a clinician

Book your free 20-minute consultation with our specialist midwife. Confirm the test that's right for you.

02

Consent + collect

Complete your consent form online, receive your kit, and collect your sample at home or via a clinic of your choice.

03

Results + follow-up

Your results are reviewed by your midwife. We share them with you securely, and book a follow-up consultation with onward referrals if your result is high-risk.

Clinic network

200+ collection points across the UK

A simple, low-cost option with flexible scheduling. For many patients, this is the quickest and most practical way to complete the test.

200+
Partners
+£40
Add-on cost
2d
Avg booking

This map is served by Google Maps, which sets its own cookies on your device.

Partner clinics are also listed below. How we use cookies

FAQ

Frequently asked questions.

How much does VeriSeq v2 NIPT cost?

VeriSeq v2 NIPT starts at £325. The price includes a free 20-minute midwife consultation, the test kit shipped to you, lab analysis on the Illumina VeriSeq v2 platform at TDL Genetics in the UK, and a clinical-grade report reviewed by your midwife. A specialist follow-up consultation is offered if your result is high-risk.

When can I take VeriSeq v2 NIPT during pregnancy?

VeriSeq v2 NIPT is suitable from 10 weeks for singleton and twin pregnancies, including IVF pregnancies (own-egg or egg-donor). We don't recommend it for triplet or higher-order pregnancies, or if you have a history of chromosomal abnormalities, parental mosaicism, fetal demise, an active malignancy, or a previous bone-marrow / organ transplant - speak with our midwife first.

What conditions does VeriSeq v2 NIPT screen for?

VeriSeq v2 NIPT screens for the three most common chromosomal conditions - Down syndrome (Trisomy 21), Edwards syndrome (Trisomy 18) and Patau syndrome (Trisomy 13) - and can optionally report fetal sex. Its standard screen does not include sex-chromosome aneuploidies or microdeletions; our advanced NIPTs add those. Results are reviewed by your midwife; a specialist follow-up consultation is offered if your result is high-risk.

How accurate is VeriSeq v2 NIPT?

Detection rates exceed 99% for Down's syndrome (Trisomy 21); detection for Edwards' (T18) and Patau's (T13) is also high but somewhat lower, around 93-99%. NIPT is a screening test - high-risk results should be confirmed with a diagnostic procedure such as CVS or amniocentesis. If your result is high-risk our specialist team will book a follow-up consultation to talk you through next steps.

Who runs the VeriSeq v2 analysis, and how fast are results?

Your sample is analysed on Illumina's VeriSeq NIPT Solution v2 - a whole-genome sequencing NIPT platform - at TDL Genetics (The Doctors Laboratory), one of the UK's largest independent laboratories. Samples are processed and reported six days a week, which is what gives the test its fast, typically 3-4 day turnaround.

Do I need a GP or hospital referral for VeriSeq v2 NIPT?

No. Anyone aged 18+ can book VeriSeq v2 NIPT directly with Jeen Health. The kit ships 2-3 days after your free 20-minute midwife consultation; your midwife reviews every report and a specialist follow-up is offered if your result is high-risk.

How we estimate "affects ~1 in N pregnancies"

The "1 in N" is an approximate UK total-birth prevalence - how often, across all births (live births plus stillbirths and terminations for fetal anomaly), a pregnancy is affected by one of the conditions this screen covers. We take the published birth prevalence of each condition, add them together, and express the total as "1 in N". The three autosomal trisomies are anchored to NCARDRS England 2022 (NHS England Digital).

This panel (3 conditions):

  • Trisomy 21 (Down's syndrome) - 30.2 per 10,000 (≈1 in 331)
  • Trisomy 18 (Edwards' syndrome) - 8.7 per 10,000 (≈1 in 1,150)
  • Trisomy 13 (Patau's syndrome) - 3.4 per 10,000 (≈1 in 2,900)

Combined: 42.3 per 10,000 births ≈ 1 in 240.

This is a population detection rate, not your personal risk - your own risk depends on maternal age, family history and other factors, and a screen result is not a diagnosis. Because each test covers a different set of conditions, the figures are not directly comparable between tests.

Sources: autosomal trisomies - NCARDRS England 2022 (NHS England Digital).

Get in touch

Talk to a specialist.

Our team is here to help. Whether you're curious about testing, your results, or what's right for you - we're a message away.

Book a consultation